These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 17257836)
21. Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis. Li S; Wang B; Xu Y; Zhang J Mol Cancer; 2011 Feb; 10():18. PubMed ID: 21314984 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of autotaxin production or activity blocks lysophosphatidylcholine-induced migration of human breast cancer and melanoma cells. Gaetano CG; Samadi N; Tomsig JL; Macdonald TL; Lynch KR; Brindley DN Mol Carcinog; 2009 Sep; 48(9):801-9. PubMed ID: 19204929 [TBL] [Abstract][Full Text] [Related]
24. [Clinical introduction of lysophosphatidic acid and autotaxin assays]. Yatomi Y Rinsho Byori; 2010 Jun; 58(6):631-5. PubMed ID: 20662276 [TBL] [Abstract][Full Text] [Related]
25. Regulation and biological activities of the autotaxin-LPA axis. van Meeteren LA; Moolenaar WH Prog Lipid Res; 2007 Mar; 46(2):145-60. PubMed ID: 17459484 [TBL] [Abstract][Full Text] [Related]
26. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. Umezu-Goto M; Kishi Y; Taira A; Hama K; Dohmae N; Takio K; Yamori T; Mills GB; Inoue K; Aoki J; Arai H J Cell Biol; 2002 Jul; 158(2):227-33. PubMed ID: 12119361 [TBL] [Abstract][Full Text] [Related]
27. Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D. van Meeteren LA; Brinkmann V; Saulnier-Blache JS; Lynch KR; Moolenaar WH Cancer Lett; 2008 Aug; 266(2):203-8. PubMed ID: 18378389 [TBL] [Abstract][Full Text] [Related]
28. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. Watanabe N; Ikeda H; Nakamura K; Ohkawa R; Kume Y; Aoki J; Hama K; Okudaira S; Tanaka M; Tomiya T; Yanase M; Tejima K; Nishikawa T; Arai M; Arai H; Omata M; Fujiwara K; Yatomi Y J Clin Gastroenterol; 2007 Jul; 41(6):616-23. PubMed ID: 17577119 [TBL] [Abstract][Full Text] [Related]
29. Autotaxin: a protein with two faces. Tania M; Khan MA; Zhang H; Li J; Song Y Biochem Biophys Res Commun; 2010 Oct; 401(4):493-7. PubMed ID: 20888793 [TBL] [Abstract][Full Text] [Related]
30. Dual activity lysophosphatidic acid receptor pan-antagonist/autotaxin inhibitor reduces breast cancer cell migration in vitro and causes tumor regression in vivo. Zhang H; Xu X; Gajewiak J; Tsukahara R; Fujiwara Y; Liu J; Fells JI; Perygin D; Parrill AL; Tigyi G; Prestwich GD Cancer Res; 2009 Jul; 69(13):5441-9. PubMed ID: 19509223 [TBL] [Abstract][Full Text] [Related]
31. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts. David M; Wannecq E; Descotes F; Jansen S; Deux B; Ribeiro J; Serre CM; Grès S; Bendriss-Vermare N; Bollen M; Saez S; Aoki J; Saulnier-Blache JS; Clézardin P; Peyruchaud O PLoS One; 2010 Mar; 5(3):e9741. PubMed ID: 20305819 [TBL] [Abstract][Full Text] [Related]
32. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. van Meeteren LA; Ruurs P; Stortelers C; Bouwman P; van Rooijen MA; Pradère JP; Pettit TR; Wakelam MJ; Saulnier-Blache JS; Mummery CL; Moolenaar WH; Jonkers J Mol Cell Biol; 2006 Jul; 26(13):5015-22. PubMed ID: 16782887 [TBL] [Abstract][Full Text] [Related]
33. Novel point mutations attenuate autotaxin activity. Koh E; Bandle RW; Roberts DD; Stracke ML; Clair T Lipids Health Dis; 2009 Feb; 8():4. PubMed ID: 19222837 [TBL] [Abstract][Full Text] [Related]
34. Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases. Gendaszewska-Darmach E Acta Biochim Pol; 2008; 55(2):227-40. PubMed ID: 18560605 [TBL] [Abstract][Full Text] [Related]
35. ATX-LPA axis induces expression of OPN in hepatic cancer cell SMMC7721. Zhang R; Zhang Z; Pan X; Huang X; Huang Z; Zhang G Anat Rec (Hoboken); 2011 Mar; 294(3):406-11. PubMed ID: 21337710 [TBL] [Abstract][Full Text] [Related]
37. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. Hama K; Aoki J; Fukaya M; Kishi Y; Sakai T; Suzuki R; Ohta H; Yamori T; Watanabe M; Chun J; Arai H J Biol Chem; 2004 Apr; 279(17):17634-9. PubMed ID: 14744855 [TBL] [Abstract][Full Text] [Related]
38. Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression. Panupinthu N; Lee HY; Mills GB Br J Cancer; 2010 Mar; 102(6):941-6. PubMed ID: 20234370 [TBL] [Abstract][Full Text] [Related]
39. Submucosal connective tissue-type mast cells contribute to the production of lysophosphatidic acid (LPA) in the gastrointestinal tract through the secretion of autotaxin (ATX)/lysophospholipase D (lysoPLD). Mori K; Kitayama J; Aoki J; Kishi Y; Shida D; Yamashita H; Arai H; Nagawa H Virchows Arch; 2007 Jul; 451(1):47-56. PubMed ID: 17554559 [TBL] [Abstract][Full Text] [Related]
40. Optimization of a pipemidic acid autotaxin inhibitor. Hoeglund AB; Bostic HE; Howard AL; Wanjala IW; Best MD; Baker DL; Parrill AL J Med Chem; 2010 Feb; 53(3):1056-66. PubMed ID: 20041668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]